Chemical Name: N-(4-(4-Bromophenyl)thiazol-2-yl)-2-((4-methylphenyl)sulfonamido)-5-(trifluoromethyl)benzamide
USP2 inhibitor
Molekulargewicht:
596.44
Reinheit:
>98% by HPLC NMR (conforms)
Formulierung:
White solid
Formel:
C24H17BrF3N3O3S2
Anwendungsbeschreibung:
MS102 is an orally bioavailable derivative (IC50 = 5.46 µM) of the USP2 inhibitor ML364.1 It displayed improved USP2 inhibition efficacy and improved antiviral activity (SARS-CoV-2 HepG2 and Calu-3 cells) compared to ML364. Antiviral activity of MS102 is via inhibition of the deubquitinase activity of USP2 on ACE2 resulting in reduction of ACE2 levels. MS102 significantly reduces V-domain Ig suppressor of T cell activation (VISTA) protein abundance in syngeneic mouse tumor models to enhance T cell response and synergizes with anti-PD-1 immunotherapy.2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten